Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parasitic Diseases

  Free Subscription


Articles published in Exp Parasitol

Retrieve available abstracts of 87 articles:
HTML format



Single Articles


    March 2024
  1. PEREIRA IAG, Freitas CS, Camara RSB, Jesus MM, et al
    Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
    Exp Parasitol. 2024 Mar 19:108743. doi: 10.1016/j.exppara.2024.108743.
    PubMed     Abstract available


    February 2024
  2. BALIOVA M, Jursky F
    Manganese- and zinc-coordinated interaction of Schistosoma japonicum glutathione S-transferase with neurotransmitter transporters GlyT1 and GAT3 in vitro.
    Exp Parasitol. 2024;259:108721.
    PubMed     Abstract available


  3. AKRAMOVA F, Shakarbaev U, Paluaniyazova D, Akbarov A, et al
    Assessing the effectiveness of fenbendazole supramolecular complexes against schistosomiasis, monieziosis and parabronemosis in sheep.
    Exp Parasitol. 2024;258:108714.
    PubMed     Abstract available


  4. DEEPACHANDI B, Weerasinghe S, Gunathileka H, Soysa P, et al
    In vitro growth of Leishmania parasites from biopsy samples of suspected cutaneous and visceral leishmaniasis cases in Sri Lanka: An observational study.
    Exp Parasitol. 2024 Feb 11:108710. doi: 10.1016/j.exppara.2024.108710.
    PubMed     Abstract available


  5. PAIVA MACHADO F, da Silva Rangel L, Farias Gomes K, Albuquerque Dos Santos JA, et al
    Potential of Ocotea indecora (Schott) Mez essential oil nanoemulsion in schistosomiasis control: Molluscicidal effects.
    Exp Parasitol. 2024 Feb 8:108717. doi: 10.1016/j.exppara.2024.108717.
    PubMed     Abstract available


  6. DAWOOD WA, Fisher G, Kinnen F, Anzenhofer C, et al
    Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Exp Parasitol. 2024 Feb 8:108716. doi: 10.1016/j.exppara.2024.108716.
    PubMed     Abstract available


  7. ROSA AAD, Brandao-Bezerra L, Correa CL, Amaral G Da-Silva S, et al
    Changes in splenic tissue and immune response profile of Schistosoma mansoni infected mice submitted to chronic ethanol intake.
    Exp Parasitol. 2024 Feb 1:108706. doi: 10.1016/j.exppara.2024.108706.
    PubMed     Abstract available


    January 2024
  8. ZHANG QZ, Liu JH, Gao YR, Liang J, et al
    Effect of macrophage polarization on parasitic protection against type 1 diabetes mellitus.
    Exp Parasitol. 2024;256:108649.
    PubMed     Abstract available


    December 2023
  9. KUMAR V, Kumari S, Ranjan R, Kumar A, et al
    In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
    Exp Parasitol. 2023 Dec 22:108688. doi: 10.1016/j.exppara.2023.108688.
    PubMed     Abstract available


  10. WIJNANT GJ, Moulik S, Chatterjee K, Das NK, et al
    Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL).
    Exp Parasitol. 2023 Dec 17:108687. doi: 10.1016/j.exppara.2023.108687.
    PubMed     Abstract available


    November 2023
  11. DE LUNA ROCHA TC, Dos Santos Lima MJ, Nunes do Nascimento JL, Ferreira de Oliveira J, et al
    Development and evaluation of the in vitro schistosomicidal activity of solid dispersions based on 2-(-5-bromo-1-H-indole-3-yl-methylene)-N-(naphthalene-1-ylhydrazine-carbothiamide.
    Exp Parasitol. 2023 Nov 14:108626. doi: 10.1016/j.exppara.2023.108626.
    PubMed     Abstract available


  12. PATIDAR A, Shukla D, Bodhale N, Saha B, et al
    TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4(+) T-cell subsets in Leishmania donovani infection.
    Exp Parasitol. 2023 Nov 8:108645. doi: 10.1016/j.exppara.2023.108645.
    PubMed     Abstract available


    October 2023
  13. SANTOS EV, Damasceno JD, Obonaga R, Rosales R, et al
    The dynamic subcellular localisation of Rad1 is cell cycle dependent in Leishmania major.
    Exp Parasitol. 2023 Oct 31:108639. doi: 10.1016/j.exppara.2023.108639.
    PubMed     Abstract available


  14. GOMES DA SILVA B, de Sousa IRA, do Nascimento Santos LA, Dos Santos VHB, et al
    Potential of pharmaceutical formulation based on Morinda citrifolia extract for the treatment of schistosomiasis.
    Exp Parasitol. 2023 Oct 14:108617. doi: 10.1016/j.exppara.2023.108617.
    PubMed     Abstract available


    September 2023
  15. PARN S, Lewis G, Knight M
    Inhibition of carbonic anhydrase using aspirin is a novel method to block schistosomiasis infection of the parasitic trematode, Schistosoma mansoni, in the intermediate snail host, Biomphalaria glabrata.
    Exp Parasitol. 2023;254:108618.
    PubMed     Abstract available


  16. SHARIFI F, Mohamadi N, Afgar A, Oliaee RT, et al
    Anti-leishmanial, immunomodulatory and additive potential effect of Piperine on Leishmania major: The in silico and in vitro study of Piperine and its combination.
    Exp Parasitol. 2023 Sep 2:108607. doi: 10.1016/j.exppara.2023.108607.
    PubMed     Abstract available


    August 2023
  17. ZOHRABI T, Azimi-Resketi M, Talaei F, Yaghoubi M, et al
    Knocking down the expression of the molecular motors, myosin A, C and F genes in Toxoplasma gondii to decrease the parasite virulence.
    Exp Parasitol. 2023;251:108565.
    PubMed     Abstract available


    July 2023
  18. ALGABBANI Q
    Nanotechnology: A promising strategy for the control of parasitic infections.
    Exp Parasitol. 2023;250:108548.
    PubMed     Abstract available


    June 2023
  19. DIAS IHL, Fonseca ALS, Sousa SRM, Goveia CO, et al
    Experimental infection with Schistosoma mansoni from Belem, Para, Brazil: Strains newly isolated vs. laboratory maintained.
    Exp Parasitol. 2023 Jun 26:108573. doi: 10.1016/j.exppara.2023.108573.
    PubMed     Abstract available


  20. SALMAN AA, Goldring JPD
    Expression and copper binding studies of a Plasmodium falciparum protein with Cox19 copper binding motifs.
    Exp Parasitol. 2023 Jun 20:108572. doi: 10.1016/j.exppara.2023.108572.
    PubMed     Abstract available


  21. MOGAHED NMFH, El-Temsahy MM, Abou-El-Naga IF, Makled SO, et al
    Loading praziquantel within solid lipid nanoparticles improved its schistosomicidal efficacy against the jeuvenile stage.
    Exp Parasitol. 2023 Jun 5:108552. doi: 10.1016/j.exppara.2023.108552.
    PubMed    


  22. AFONSO RC, Yien RMK, de Siqueira LBO, Simas NK, et al
    Promising natural products for the treatment of cutaneous leishmaniasis: A review of in vitro and in vivo studies.
    Exp Parasitol. 2023;251:108554.
    PubMed     Abstract available


    May 2023
  23. FREITAS CS, Santiago SS, Lage DP, Antinarelli LMR, et al
    In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
    Exp Parasitol. 2023;251:108555.
    PubMed     Abstract available


  24. GONCALVES-OLIVEIRA LF, Peixoto JF, Dias-Lopes G, Souza da Silva F, et al
    Assessing nystatin cream treatment efficacy against Leishmania (L.) amazonensis infection in BALB/c model.
    Exp Parasitol. 2023 May 15:108547. doi: 10.1016/j.exppara.2023.108547.
    PubMed     Abstract available


    March 2023
  25. TEH-POOT CF, Dzul-Huchim VM, Mercado JM, Villanueva-Lizama LE, et al
    A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry.
    Exp Parasitol. 2023 Mar 31:108519. doi: 10.1016/j.exppara.2023.108519.
    PubMed     Abstract available


  26. MANSOUR SM, Ibrahim AM
    Differentiation between Bulinus truncatus and Bulinus hexaploidus by morphological characters, chromosomal study and compatibility with Schistosoma haematobium.
    Exp Parasitol. 2023 Mar 11:108502. doi: 10.1016/j.exppara.2023.108502.
    PubMed     Abstract available


  27. ZHONG H, Qin F, Ren Y, Li X, et al
    Functional characterization of differentially expressed proteins coming from unisexual and bisexual infected Schistosoma japonicum female worms.
    Exp Parasitol. 2023 Mar 11:108504. doi: 10.1016/j.exppara.2023.108504.
    PubMed     Abstract available


    February 2023
  28. PAULINO S, Santos L, Rabello M, da Silva P, et al
    Development of solid dispersions based on 3- (2,6-difluorobenzyl) -5- (5-bromo-1H-indol-3-ylmethylene) thiazolidine-2,4-dione for schistosomicidal treatment.
    Exp Parasitol. 2023 Feb 8:108455. doi: 10.1016/j.exppara.2022.108455.
    PubMed     Abstract available


    January 2023
  29. SHARMA A, Chauhan BS, Yadav K, Chaudhary NR, et al
    Molecular and immunological characterization of the calcyclin binding protein in rodent malaria parasite.
    Exp Parasitol. 2023 Jan 24:108475. doi: 10.1016/j.exppara.2023.108475.
    PubMed     Abstract available


  30. FERREIRA BA, Coser EM, Saborito C, Yamashiro-Kanashiro EH, et al
    In vitro miltefosine and amphotericin B susceptibility of strains and clinical isolates of Leishmania species endemic in Brazil that cause tegumentary leishmaniasis.
    Exp Parasitol. 2023;246:108462.
    PubMed     Abstract available


    December 2022
  31. RAHMANIPOUR M, Mohebali M, Koosha M, Kazemirad E, et al
    Effect of Leishmania RNA virus 2 on virulence factors and cytokines gene expression in a human macrophage infected with Leishmania major: A preliminary study.
    Exp Parasitol. 2022 Dec 31:108459. doi: 10.1016/j.exppara.2022.108459.
    PubMed     Abstract available


  32. DARIF D, Nait Irahal I, Hammi I, Kihel A, et al
    Capparis spinosa inhibits Leishmania major growth through nitric oxide production in vitro and arginase inhibition in silico.
    Exp Parasitol. 2022 Dec 26:108452. doi: 10.1016/j.exppara.2022.108452.
    PubMed     Abstract available


  33. MAHOR H, Mukherjee A, Sarkar A, Saha B, et al
    Anti-leishmanial therapy: Caught between drugs and immune targets.
    Exp Parasitol. 2022 Dec 23:108441. doi: 10.1016/j.exppara.2022.108441.
    PubMed     Abstract available


  34. FOTOOHI S, Radfar MH, Afgar A, Harandi MF, et al
    Anti-echinococcal effects of sumac, Rhus coriaria, in a murine model of cystic echinococcosis: Parasitological and molecular evaluation.
    Exp Parasitol. 2022;243:108406.
    PubMed     Abstract available


    November 2022
  35. YOUSEFI S, Paksa A, Gorouhi MA, Alizadeh I, et al
    Determination of the feeding behavior of Phlebotomus sergenti using multiplex PCR and tent-baited traps in a new focus of Anthroponotic Cutaneous Leishmaniasis in the southeast of Iran.
    Exp Parasitol. 2022 Nov 15:108426. doi: 10.1016/j.exppara.2022.108426.
    PubMed     Abstract available


  36. CHIAMAH OC, Ubachukwu PO, Okafor FC, Shoyinka SVO, et al
    Low doses and short duration of prednisolone administration in guinea pigs experimentally infected with Schistosoma haematobium: Histopathology of liver and lungs.
    Exp Parasitol. 2022;244:108425.
    PubMed     Abstract available


  37. PERALES MACEDO DMB, Diaz Pernett SC, Diaz Gonzalez MG, Torres Nieves GM, et al
    Autochthonous transmission of the Indomalayan parasite, Transversotrema patialense, in the Caribbean: Molecular, morphological, and experimental evidence.
    Exp Parasitol. 2022;242:108368.
    PubMed     Abstract available


    October 2022
  38. OLIVEIRA IHR, Kjeldsen F, Melo-Braga MN, Verano-Braga T, et al
    Assessing the effects of Leishmania (Leishmania) infantum and L. (L.) amazonensis infections in macrophages using a quantitative proteome approach.
    Exp Parasitol. 2022;243:108413.
    PubMed     Abstract available


  39. SHEKHAR S, Bhowmick K, Dhar SK
    Role of PfMYST in DNA replication in Plasmodium falciparum.
    Exp Parasitol. 2022 Oct 10:108396. doi: 10.1016/j.exppara.2022.108396.
    PubMed     Abstract available


  40. GOMES ECS, Barbosa Junior WL, Melo FL
    Evaluation of SmITS1-LAMP performance to diagnosis schistosomiasis in human stool samples from an endemic area in Brazil.
    Exp Parasitol. 2022 Oct 4:108389. doi: 10.1016/j.exppara.2022.108389.
    PubMed     Abstract available


  41. GANJI A, Jalali-Mashayekhi F, Hajihossein R, Eslamirad Z, et al
    Anti-parasitic effects of resveratrol on protoscolices and hydatid cyst layers.
    Exp Parasitol. 2022;241:108360.
    PubMed     Abstract available


    September 2022
  42. SALAH F, Maher K, Demerdash Z, El Baz H, et al
    Lab-scale production of anti-Schistosoma monoclonal antibodies by hybridoma culturing in serum free medium: Enhancement of growth, cryopreservation survival rate, and diagnostic accuracy.
    Exp Parasitol. 2022 Sep 27:108390. doi: 10.1016/j.exppara.2022.108390.
    PubMed     Abstract available


  43. GIRALDO M, Upegui YA, Higuita-Castro JL, Gonzalez LA, et al
    Effect of the variation in the extracellular concentration of l-arginine in the physiology of Leishmania (Viannia) braziliensis and its susceptibility to some antileishmanial drugs.
    Exp Parasitol. 2022 Sep 27:108395. doi: 10.1016/j.exppara.2022.108395.
    PubMed     Abstract available


  44. BRANDAO-BEZERRA L, Aparecida da Rosa A, Figueiredo de Oliveira RM, Neves RH, et al
    Impact of acute schistosomiasis mansoni and long-term ethanol intake on mouse liver pathology.
    Exp Parasitol. 2022 Sep 26:108388. doi: 10.1016/j.exppara.2022.108388.
    PubMed     Abstract available


  45. KUAPRASERT B, Chitnumsub P, Leartsakulpanich U, Suginta W, et al
    Dual role of azo compounds in inhibiting Plasmodium falciparum adenosine deaminase and hemozoin biocrystallization.
    Exp Parasitol. 2022 Sep 22:108384. doi: 10.1016/j.exppara.2022.108384.
    PubMed     Abstract available


  46. CUNHA ARAUJO IA, Cristina de Paula R, Alves CL, Faria KF, et al
    In vitro efficacy of isoflavonoids and terpenes against Leishmania (Leishmania) infantum and L. amazonensis.
    Exp Parasitol. 2022 Sep 21:108383. doi: 10.1016/j.exppara.2022.108383.
    PubMed     Abstract available


  47. STARKLOFF NC, Hartman RB, Civitello DJ
    Snail juvenile growth rate as a rapid predictor of the transmission potential of parasitizing human schistosomes.
    Exp Parasitol. 2022 Sep 9:108378. doi: 10.1016/j.exppara.2022.108378.
    PubMed     Abstract available


    August 2022
  48. MUKHERJEE N, Banerjee S, Amin SA, Jha T, et al
    Host P2X7R-p38MAPK axis mediated intra-macrophage leishmanicidal activity of Spergulin-A.
    Exp Parasitol. 2022 Aug 22:108365. doi: 10.1016/j.exppara.2022.108365.
    PubMed     Abstract available


  49. LIMA TC, Magalhaes LG, de L Paula LA, Cunha WR, et al
    In vivo schistosomicidal activity of (+/-)-licarin A-loaded poly(epsilon-caprolactone) nanoparticles.
    Exp Parasitol. 2022 Aug 20:108357. doi: 10.1016/j.exppara.2022.108357.
    PubMed     Abstract available


  50. ALVES AF, Pereira RA, Rodrigues MA, Campos LS, et al
    Leishmania (L.) infantum BH401 strain induces classic renal lesions in dogs: Histological and confocal microscopy study.
    Exp Parasitol. 2022 Aug 17:108342. doi: 10.1016/j.exppara.2022.108342.
    PubMed     Abstract available


  51. SABERI R, Fakhar M, Hajjaran H, Abbaszadeh Afshar MJ, et al
    Leishmania RNA virus 2 (LRV2) exacerbates dermal lesions caused by Leishmania major and comparatively unresponsive to meglumine antimoniate treatment.
    Exp Parasitol. 2022 Aug 3:108340. doi: 10.1016/j.exppara.2022.108340.
    PubMed     Abstract available


    July 2022
  52. DE MORAIS RCS, de Melo MGN, de Goes TC, Pessoa E Silva R, et al
    Clinical-therapeutic follow-up of patients with American cutaneous leishmaniasis caused by different Leishmania spp. in Brazil.
    Exp Parasitol. 2022 Jul 30:108338. doi: 10.1016/j.exppara.2022.108338.
    PubMed     Abstract available


  53. DOS REIS LFC, Cerdeira CD, Gagliano GS, de Figueiredo ABT, et al
    Alternate-day fasting, a high-sucrose/caloric diet and praziquantel treatment influence biochemical and behavioral parameters during Schistosoma mansoni infection in male BALB/c mice.
    Exp Parasitol. 2022;240:108316.
    PubMed     Abstract available


  54. OLIVEIRA FMS, Kraemer L, Cavalcanti da Silva C, Nogueira DS, et al
    Nitric oxide contributes to liver inflammation and parasitic burden control in Ascaris suum infection.
    Exp Parasitol. 2022;238:108267.
    PubMed     Abstract available


  55. CAVALLONE IN, de Lima SKS, Oliveira KS, Passero LFD, et al
    Histological and neuronal changes in the duodenum of hamsters infected with Leishmania (Leishmania) infantum.
    Exp Parasitol. 2022;239:108315.
    PubMed     Abstract available


    June 2022
  56. ELMALAWANY AM, Osman GY, Elashwal MS, Mohamed AH, et al
    Protective role of Balanities aegyptiaca fruit aqueous extract in mice infected with Schistosoma mansoni.
    Exp Parasitol. 2022;239:108290.
    PubMed     Abstract available


  57. SAAD AE, Ashour DS, Osman EM
    Different panel of toll-like receptors expression during chronic Schistosoma mansoni infection in experimental animals.
    Exp Parasitol. 2022;239:108317.
    PubMed     Abstract available


  58. KUANG Z, Zhang C, Meng Y, Yi F, et al
    Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: An effective method for identification and phylogenetic analysis of Leishmania species.
    Exp Parasitol. 2022 Jun 25:108278. doi: 10.1016/j.exppara.2022.108278.
    PubMed     Abstract available


  59. MIURA M, Mitsui Y, Aoki Y, Kato K, et al
    A new accumulation assay of Schistosoma mansoni miracidia using square capillary glass tubes.
    Exp Parasitol. 2022;239:108313.
    PubMed     Abstract available


  60. REN Y, Li M, Shi Y, Liu P, et al
    Schistosoma japonicum proteins that interact with the gynecophoral canal protein identified using a yeast two-hybrid system.
    Exp Parasitol. 2022;239:108305.
    PubMed     Abstract available


  61. VAKILI B, Nezafat N, Negahdaripour M, Ghasemi Y, et al
    A structural vaccinology approach for in silico designing of a potential self-assembled nanovaccine against Leishmania infantum.
    Exp Parasitol. 2022;239:108295.
    PubMed     Abstract available


  62. ALVES ML, Silva DTD, Spada JCP, Leonel JAF, et al
    Use of the intradermal leishmanin test (Montenegro skin test) for feline visceral leishmaniosis: Detection of cellular immunity.
    Exp Parasitol. 2022 Jun 6:108294. doi: 10.1016/j.exppara.2022.108294.
    PubMed     Abstract available


  63. SABRA AA, Salem MB, William S, Hammam OA, et al
    Itraconazole, a cytochrome P450 inhibitor, enhanced the efficacy of praziquantel against Schistosoma mansoni infection and alleviated liver injury in mice.
    Exp Parasitol. 2022 Jun 3:108293. doi: 10.1016/j.exppara.2022.108293.
    PubMed     Abstract available


  64. GHOSH R, Jawed JJ, Roy N, Mandal S, et al
    Regulatory role of Transcription factor-EB (TFEB) in parasite control through alteration of antigen presentation in visceral leishmaniasis.
    Exp Parasitol. 2022 Jun 2:108286. doi: 10.1016/j.exppara.2022.108286.
    PubMed     Abstract available


  65. ELZOHEIRY MA, Elmehankar MS, Aboukamar WA, El-Gamal R, et al
    Fluconazole as Schistosoma mansoni cytochrome P450 inhibitor: In vivo murine experimental study.
    Exp Parasitol. 2022 Jun 2:108291. doi: 10.1016/j.exppara.2022.108291.
    PubMed     Abstract available


    May 2022
  66. RAHMAN MM, McFadden G, Ruthel G, Herbert DR, et al
    Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni.
    Exp Parasitol. 2022 May 19:108263. doi: 10.1016/j.exppara.2022.108263.
    PubMed     Abstract available


  67. TEIXEIRA RR, Rodrigues Gazolla PA, Borsodi MPG, Castro Ferreira MM, et al
    Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.
    Exp Parasitol. 2022 May 5:108269. doi: 10.1016/j.exppara.2022.108269.
    PubMed     Abstract available


  68. YE Z, Ni W, Zhang J, Zhang Y, et al
    Molecular characterization of a profilin gene from a parasitic ciliate Cryptocaryon irritans.
    Exp Parasitol. 2022;236-237:108248.
    PubMed     Abstract available


  69. SOARES LA, Matias IC, Silva SS, Ramos MEO, et al
    Parasitological, serological and molecular diagnosis of Dirofilaria immitis in dogs in Northeastern Brazil.
    Exp Parasitol. 2022;236-237:108233.
    PubMed     Abstract available


    April 2022
  70. FAHMY AM, William S, Hegab A, Tm D, et al
    Schistosomicidal and hepatoprotective activity of gamma-aminobutyric acid (GABA) alone or combined with praziquantel against Schistosoma mansoni infection in murine model.
    Exp Parasitol. 2022 Apr 18:108260. doi: 10.1016/j.exppara.2022.108260.
    PubMed     Abstract available


  71. BRUSTOLIN AA, Franzoi NM, Ramos-Milare ACFH, Tanoshi CA, et al
    A standardized intraperitoneal Glucantime for experimental treatment of cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice.
    Exp Parasitol. 2022;236-237:108259.
    PubMed     Abstract available


  72. ADEL MADBOULY N, Emam M, Ayman M, Ayman M, et al
    In vitro and in vivo impacts of nifedipine and diltiazem on praziquantel chemotherapy in murine Schistosoma mansoni.
    Exp Parasitol. 2022;236-237:108256.
    PubMed     Abstract available


  73. PANDEY RK, Ojha R, Devender M, Sebastian P, et al
    Febrifugine dihydrochloride as a new oral chemotherapeutic agent against visceral leishmaniasis infection.
    Exp Parasitol. 2022;236-237:108250.
    PubMed     Abstract available


  74. GOUVEIA ALA, Santos FAB, Alves LC, Cruz-Filho IJ, et al
    Thiazolidine derivatives: In vitro toxicity assessment against promastigote and amastigote forms of Leishmania infantum and ultrastructural study.
    Exp Parasitol. 2022;236-237:108253.
    PubMed     Abstract available


  75. CARSON JP, Robinson MW, Ramm GA, Gobert GN, et al
    Synthetic peptides derived from the Schistosoma mansoni secretory protein Sm16 induce contrasting responses in hepatic stellate cells.
    Exp Parasitol. 2022;236-237:108255.
    PubMed     Abstract available


    March 2022
  76. AVILA BRUSTOLIN A, Fernandes Herculano Ramos-Milare AC, Perles de Mello TF, Alessi Aristides SM, et al
    In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis.
    Exp Parasitol. 2022;236-237:108244.
    PubMed     Abstract available


    December 2021
  77. SALAZAR-VILLAMIZAR ME, Escobar P
    In vitro selection of ketoconazole-pentamidine-resistant Leishmania (Viannia) braziliensis strains.
    Exp Parasitol. 2021;233:108206.
    PubMed     Abstract available


  78. MENDONCA DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, et al
    Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study.
    Exp Parasitol. 2021 Dec 27:108205. doi: 10.1016/j.exppara.2021.108205.
    PubMed     Abstract available


    November 2021
  79. CHEN H, Li G, Zhang J, Zheng T, et al
    Sodium butyrate ameliorates Schistosoma japonicum-induced liver fibrosis by inhibiting HMGB1 expression.
    Exp Parasitol. 2021 Nov 1:108171. doi: 10.1016/j.exppara.2021.108171.
    PubMed     Abstract available


    September 2021
  80. GOMES MT, Paes-Vieira L, Gomes-Vieira AL, Cosentino-Gomes D, et al
    3-Bromopyruvate: A new strategy for inhibition of glycolytic enzymes in Leishmania amazonensis.
    Exp Parasitol. 2021;229:108154.
    PubMed     Abstract available


    July 2021
  81. MODABBERI F, Ghadimi SN, Shahriarirad R, Nadimi E, et al
    Stereological analysis of liver, spleen and bone of Leishmania infantum-experimentally infected hamsters.
    Exp Parasitol. 2021;228:108137.
    PubMed     Abstract available


  82. FAHMY A, Abuelenain GL, Rasheed N, Abdou A, et al
    'de Novo' repurposing of Daflon as anti-intestinal parasitic drug in experimental giardiasis.
    Exp Parasitol. 2021;226-227:108124.
    PubMed     Abstract available


    June 2021
  83. GONTIJO VS, Colombo FA, Ferreira Espuri P, Freitas PG, et al
    In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route.
    Exp Parasitol. 2021 Jun 16:108123. doi: 10.1016/j.exppara.2021.108123.
    PubMed     Abstract available


  84. KALANI M, Shams SR, Namdarnia S, Choopanizadeh M, et al
    Interleukine-22 gene variants are associated with susceptibility to visceral leishmaniasis.
    Exp Parasitol. 2021 Jun 8:108122. doi: 10.1016/j.exppara.2021.108122.
    PubMed     Abstract available


  85. SEBAI E, Abidi A, Serairi R, Marzouki M, et al
    Essential oil of Mentha pulegium induces anthelmintic effects and reduces parasite-associated oxidative stress in rodent model.
    Exp Parasitol. 2021;225:108105.
    PubMed     Abstract available


    May 2021
  86. USMAN MA, Usman FI, Abubakar MS, Salman AA, et al
    Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei.
    Exp Parasitol. 2021;224:108097.
    PubMed     Abstract available


  87. AULA OP, McManus DP, Mason MG, Botella JR, et al
    Rapid parasite detection utilizing a DNA dipstick.
    Exp Parasitol. 2021;224:108098.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.